Management of Dysphonia
The cornerstone of dysphonia management is laryngoscopy for persistent symptoms beyond 4 weeks or when serious pathology is suspected, followed by voice therapy as first-line treatment for most functional causes, while avoiding empiric antibiotics, corticosteroids, or antireflux medications without laryngeal visualization. 1
Initial Assessment and Red Flags
Begin by identifying dysphonia through altered voice quality, pitch, loudness, or vocal effort that impairs communication or quality of life 1. Immediately assess for factors requiring expedited laryngeal evaluation 1:
- Recent head, neck, or chest surgery
- Recent endotracheal intubation
- Concomitant neck mass
- Respiratory distress or stridor
- History of tobacco abuse
- Professional voice user status
These red flags warrant immediate laryngoscopy regardless of symptom duration 1.
The 4-Week Rule for Laryngoscopy
Perform or refer for laryngoscopy when dysphonia fails to resolve within 4 weeks, or immediately if serious underlying cause is suspected 1. This is a firm recommendation, not optional. Laryngoscopy may be performed at any time if clinically indicated 1.
Common Pitfall to Avoid
Do not obtain CT or MRI imaging before visualizing the larynx—this wastes resources and delays diagnosis 1. Direct visualization must come first.
What NOT to Do (Strong Recommendations Against)
The 2018 AAO-HNS guidelines explicitly recommend against several common practices:
- Do not routinely prescribe antibiotics for dysphonia (strong recommendation against) 1
- Do not prescribe antireflux medications (PPIs) based on symptoms alone without laryngeal visualization 1
- Do not routinely prescribe corticosteroids prior to laryngoscopy 1
These practices are common but not evidence-based. A 2012 survey found PPIs were the most common treatment by general otolaryngologists, despite lack of supporting evidence 2.
Treatment Algorithm Based on Laryngoscopy Findings
1. Voice Therapy (First-Line for Most Patients)
Always perform diagnostic laryngoscopy before prescribing voice therapy and communicate findings to the speech-language pathologist 1. Voice therapy is strongly recommended for causes amenable to this approach 1, including:
- Muscle tension dysphonia (24% of cases) 3
- Vocal fold nodules
- Functional voice disorders
- Vocal fold edema (17% of cases) 3
Voice therapy was the primary treatment in 61% of dysphonia patients in recent data 3 and remains first-line even for benign vocal fold nodules 4.
2. Surgical Intervention
Advocate for surgery when indicated for 1:
- Suspected malignancy (immediate referral)
- Symptomatic benign vocal fold lesions not responding to conservative management
- Glottic insufficiency
- Vocal fold paralysis (11% of cases) 3
Surgery should be presented as a therapeutic option, not withheld when appropriate.
3. Botulinum Toxin Injections
Offer or refer for botulinum toxin specifically for 1, 5:
- Spasmodic dysphonia
- Other laryngeal dystonias
This is a specific indication with strong evidence support.
Patient Education and Prevention
Inform all dysphonia patients about control and preventive measures 1, 5. This includes:
- Voice hygiene practices
- Avoiding vocal abuse (the most common risk factor, especially in children) 6
- Hydration
- Smoking cessation if applicable
Documentation Requirements
Document outcomes after treatment or observation, including 1:
- Resolution, improvement, or worsening of symptoms
- Changes in quality of life
- Response to interventions
This ensures continuity of care and allows assessment of treatment effectiveness.
Special Considerations
Professional Voice Users
These patients require expedited evaluation given the vocational impact 1. Consider earlier referral to laryngology specialists.
Pediatric Dysphonia
Voice abuse is the most common risk factor in children, with vocal nodules being the most frequent diagnosis 6. Conservative management with voice rest and voice therapy is recommended in early stages, with most achieving complete relief except for vocal polyps 6.
Multifactorial Etiology
Recent data shows significant numbers of patients present without a known inciting event 3. Common comorbidities include GERD/LPR (45%) and cardiovascular disease (42%) 3, but these should not drive empiric treatment without laryngeal visualization.
When Initial Treatment Fails
If patients fail initial management 2:
- Refer for voice therapy (58% of otolaryngologists do this)
- Obtain stroboscopy if not already done (47%)
- Do not simply extend PPI treatment without documented laryngeal findings
The evidence strongly supports visualization-guided treatment over empiric medication trials.